Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
6
PHILIPPINES:6
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Clinical Study With Adalimumab Biosimilar
Phase 1
Completed
- Conditions
- PharmacokineticsSafety Issues
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Laboratorios Richmond S.A.C.I.F.
- Target Recruit Count
- 150
- Registration Number
- NCT06291948
- Locations
- 🇦🇷
FP Clinical Pharma S.R.L., Buenos Aires, Argentina
A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab
Phase 1
Completed
- Conditions
- PharmacokineticsSafety Issues
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Laboratorios Richmond S.A.C.I.F.
- Target Recruit Count
- 112
- Registration Number
- NCT03919448
- Locations
- 🇦🇷
FP Clinical Pharma S.R.L., Buenos Aires, Argentina
News
No news found